A citation-based method for searching scientific literature

Priyanka Sharma, Roisin M Connolly, Evanthia T Roussos Torres, Alastair Thompson. Am Soc Clin Oncol Educ Book 2020
Times Cited: 6







List of co-cited articles
12 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.
Carsten Denkert, Sibylle Loibl, Aurelia Noske, Marc Roller, Berit Maria Müller, Martina Komor, Jan Budczies, Silvia Darb-Esfahani, Ralf Kronenwett, Claus Hanusch,[...]. J Clin Oncol 2010
33


Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer.
Dilan A Patel, Jing Xi, Jingqin Luo, Bilal Hassan, Shana Thomas, Cynthia X Ma, Jian L Campian. Breast Cancer Res Treat 2019
38
33

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers.
Sherene Loi, Damien Drubay, Sylvia Adams, Giancarlo Pruneri, Prudence A Francis, Magali Lacroix-Triki, Heikki Joensuu, Maria Vittoria Dieci, Sunil Badve, Sandra Demaria,[...]. J Clin Oncol 2019
291
33

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.
Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa,[...]. Lancet 2014
33

Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients.
Mirco Pistelli, Mariagrazia De Lisa, Zelmira Ballatore, Miriam Caramanti, Alessandra Pagliacci, Nicola Battelli, Francesca Ridolfi, Matteo Santoni, Elena Maccaroni, Raffaella Bracci,[...]. BMC Cancer 2015
79
33

Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer.
Yuka Asano, Shinichiro Kashiwagi, Naoyoshi Onoda, Satoru Noda, Hidemi Kawajiri, Tsutomu Takashima, Masahiko Ohsawa, Seiichi Kitagawa, Kosei Hirakawa. Ann Surg Oncol 2016
84
33

Clinical relevance of host immunity in breast cancer: from TILs to the clinic.
Peter Savas, Roberto Salgado, Carsten Denkert, Christos Sotiriou, Phillip K Darcy, Mark J Smyth, Sherene Loi. Nat Rev Clin Oncol 2016
428
33

Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
Carsten Denkert, Gunter von Minckwitz, Silvia Darb-Esfahani, Bianca Lederer, Barbara I Heppner, Karsten E Weber, Jan Budczies, Jens Huober, Frederick Klauschen, Jenny Furlanetto,[...]. Lancet Oncol 2018
733
33

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel.
Priyanka Sharma, Sara López-Tarruella, José Angel García-Saenz, Qamar J Khan, Henry L Gómez, Aleix Prat, Fernando Moreno, Yolanda Jerez-Gilarranz, Agustí Barnadas, Antoni C Picornell,[...]. Clin Cancer Res 2018
51
33

Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer.
Frederique Penault-Llorca, Catherine Abrial, Ines Raoelfils, Anne Cayre, Marie-Ange Mouret-Reynier, Marianne Leheurteur, Xavier Durando, Jean-Louis Achard, Pierre Gimbergues, Philippe Chollet. Hum Pathol 2008
45
33

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update.
Kimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, Shannon E McKernin, Lisa A Carey, Patrick L Fitzgibbons, Daniel F Hayes, Sunil R Lakhani, Mariana Chavez-MacGregor, Jane Perlmutter,[...]. Arch Pathol Lab Med 2020
85
33

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
Hongchao Pan, Richard Gray, Jeremy Braybrooke, Christina Davies, Carolyn Taylor, Paul McGale, Richard Peto, Kathleen I Pritchard, Jonas Bergh, Mitch Dowsett,[...]. N Engl J Med 2017
615
16



Cancer-related inflammation.
Alberto Mantovani, Paola Allavena, Antonio Sica, Frances Balkwill. Nature 2008
16

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. J Clin Oncol 2010
16

The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer.
Takeharu Yamanaka, Shigemi Matsumoto, Satoshi Teramukai, Ryota Ishiwata, Yoji Nagai, Masanori Fukushima. Oncology 2007
321
16

Microenvironmental regulation of tumor progression and metastasis.
Daniela F Quail, Johanna A Joyce. Nat Med 2013
16

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
E Senkus, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, E Rutgers, S Zackrisson, F Cardoso. Ann Oncol 2015
912
16

Prognostic significance of neutrophil-lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages.
Norifumi Harimoto, Kouki Hoshino, Ryo Muranushi, Kei Hagiwara, Takahiro Yamanaka, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Hiroshi Tanaka, Akira Watanabe,[...]. Pancreatology 2019
17
16

Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment.
Wendy Muñoz-Montaño, Paula Cabrera-Galeana, Alberto Alvarado-Miranda, Cynthia Villarreal-Garza, Alejandro Mohar, Alejandro Olvera, Enrique Bargallo-Rocha, Fernando Lara-Medina, Oscar Arrieta. Clin Breast Cancer 2020
9
16

Preoperative chemotherapy for women with operable breast cancer.
J S D Mieog, J A van der Hage, C J H van de Velde. Cochrane Database Syst Rev 2007
237
16

Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression.
Marisa M Queen, Randall E Ryan, Ryan G Holzer, Cynthia R Keller-Peck, Cheryl L Jorcyk. Cancer Res 2005
255
16

Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis.
Josee-Lyne Ethier, Danielle Desautels, Arnoud Templeton, Prakesh S Shah, Eitan Amir. Breast Cancer Res 2017
269
16

Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents.
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, Laurence Zitvogel, Guido Kroemer. Cancer Cell 2015
830
16


Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
Cornelia Liedtke, Chafika Mazouni, Kenneth R Hess, Fabrice André, Attila Tordai, Jaime A Mejia, W Fraser Symmans, Ana M Gonzalez-Angulo, Bryan Hennessy, Marjorie Green,[...]. J Clin Oncol 2008
16

Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer.
Yoshimasa Miyagawa, Ayako Yanai, Takehiro Yanagawa, Junichi Inatome, Chiyomi Egawa, Arisa Nishimukai, Kaori Takamoto, Takashi Morimoto, Yuichiro Kikawa, Hirofumi Suwa,[...]. Oncotarget 2020
8
16

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
Gunter von Minckwitz, Chiun-Sheng Huang, Max S Mano, Sibylle Loibl, Eleftherios P Mamounas, Michael Untch, Norman Wolmark, Priya Rastogi, Andreas Schneeweiss, Andres Redondo,[...]. N Engl J Med 2019
813
16

Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.
Davide Mauri, Nicholas Pavlidis, John P A Ioannidis. J Natl Cancer Inst 2005
761
16

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
Arnoud J Templeton, Mairéad G McNamara, Boštjan Šeruga, Francisco E Vera-Badillo, Priya Aneja, Alberto Ocaña, Raya Leibowitz-Amit, Guru Sonpavde, Jennifer J Knox, Ben Tran,[...]. J Natl Cancer Inst 2014
16

Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.
J A van der Hage, C J van de Velde, J P Julien, M Tubiana-Hulin, C Vandervelden, L Duchateau. J Clin Oncol 2001
740
16

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.
Antonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, Brittany E Harvey, Pamela B Mangu, John M S Bartlett, Michael Bilous, Ian O Ellis, Patrick Fitzgibbons, Wedad Hanna,[...]. J Clin Oncol 2018
635
16


Primary systemic therapy of breast cancer.
Irina Sachelarie, Michael L Grossbard, Manjeet Chadha, Sheldon Feldman, Munir Ghesani, Ronald H Blum. Oncologist 2006
114
16

The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8.
Joseph E De Larco, Beverly R K Wuertz, Leo T Furcht. Clin Cancer Res 2004
266
16

Interaction of tumor-associated macrophages and cancer chemotherapy.
Irina Larionova, Nadezhda Cherdyntseva, Tengfei Liu, Marina Patysheva, Militsa Rakina, Julia Kzhyshkowska. Oncoimmunology 2019
115
16

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
Norikazu Masuda, Soo-Jung Lee, Shoichiro Ohtani, Young-Hyuck Im, Eun-Sook Lee, Isao Yokota, Katsumasa Kuroi, Seock-Ah Im, Byeong-Woo Park, Sung-Bae Kim,[...]. N Engl J Med 2017
654
16


Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: A meta-analysis.
Xu Liu, Jing-Kun Qu, Jia Zhang, Yan Yan, Xi-Xi Zhao, Ji-Zhao Wang, Hang-Ying Qu, Lin Liu, Jian-Sheng Wang, Xiao-Yi Duan. Medicine (Baltimore) 2017
33
16


Preoperative chemotherapy in operable breast cancer.
G Bonadonna, P Valagussa, C Brambilla, L Ferrari. Lancet 1993
31
16

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.
Mitch Dowsett, Torsten O Nielsen, Roger A'Hern, John Bartlett, R Charles Coombes, Jack Cuzick, Matthew Ellis, N Lynn Henry, Judith C Hugh, Tracy Lively,[...]. J Natl Cancer Inst 2011
16


Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.
Sylvia Adams, Robert J Gray, Sandra Demaria, Lori Goldstein, Edith A Perez, Lawrence N Shulman, Silvana Martino, Molin Wang, Vicky E Jones, Thomas J Saphner,[...]. J Clin Oncol 2014
753
16

Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer.
Fabrice Andre, Maria V Dieci, Peter Dubsky, Christos Sotiriou, Giuseppe Curigliano, Carsten Denkert, Sherene Loi. Clin Cancer Res 2013
143
16


The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer.
Claudio Vernieri, Alessia Mennitto, Michele Prisciandaro, Veronica Huber, Monica Milano, Lucia Rinaldi, Maria Silvia Cona, Claudia Maggi, Benvenuto Ferrari, Siranoush Manoukian,[...]. Sci Rep 2018
28
16

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.
W Fraser Symmans, Florentia Peintinger, Christos Hatzis, Radhika Rajan, Henry Kuerer, Vicente Valero, Lina Assad, Anna Poniecka, Bryan Hennessy, Marjorie Green,[...]. J Clin Oncol 2007
851
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.